Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of synthetic method of clofarabine

A synthesis method and clofarabine technology, which are applied in chemical instruments and methods, bulk chemical production, sugar derivatives, etc., can solve the problems of high product cost, long reaction time, low yield, etc., and achieve low total cost, Easy to handle, small particle size effect

Active Publication Date: 2019-05-17
WUHAN BIOCAUSE PHARMA DEV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] The technical problem to be solved by the present invention is to overcome the long reaction time in the existing synthetic method of clofarabine, high product cost, low purity, low yield and other defects

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of synthetic method of clofarabine
  • A kind of synthetic method of clofarabine
  • A kind of synthetic method of clofarabine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0044] Example 1: Preparation of 1-bromo-2-deoxy-2-fluoro-3,5-tribenzoyl-α-D-arabinofuranose (compound I, R 1 and R 2 for benzoyl)

[0045]Add 28g of 2-deoxy-2-fluoro-1,3,5-tribenzoyl-α-D-arabinofuranose, 200mL of dichloromethane, and 36mL of hydrobromic acetic acid solution (33%) into a 500mL three-necked reaction flask , airtight, react at room temperature overnight, TLC monitoring, the reaction is completed, add 200mL ice water and stir for 15min, stand to separate layers, the organic layer is washed with 200mL×2 saturated sodium bicarbonate solution, dried over anhydrous magnesium sulfate for 2h, concentrated to dryness to obtain 24.0 g of compound III (94% yield).

Embodiment 2

[0046] Example 2: Preparation of 2,6-dichloro-9-(3′,5′-di-O-benzoyl-2′-fluoro-β-D-arabinofuranosyl)-purine (compound III)

[0047] After dissolving 24.0 g of the compound prepared in Example 1 in 200 mL of dichloromethane solution, transfer it to a 500 mL three-necked flask, add 200 mL of acetonitrile, and put in 10.0 g of 2,6-dichloropurine in turn under nitrogen protection, and put the catalyst into In the reaction flask, stir at room temperature for 12-16h. TLC: Ethyl acetate: Petroleum ether = 1:4, the reaction is complete, filter, wash the filter cake with a small amount of dichloromethane, adjust the pH of the filtrate to 6-8 with glacial acetic acid, filter again if there is precipitation, concentrate the mother liquor to dryness, add 40 mL of ethyl acetate Heat the ester to dissolve, add 40mL of methanol while it is hot, cool and crystallize, cool down to room temperature naturally, cool in an ice bath for 2h, filter, and dry to obtain the product.

[0048] The presen...

Embodiment 3

[0052] Example 3: Preparation of 2,6-dichloro-9-(3',5'-di-O-benzoyl-2'-fluoro-β-D-arabinofuranosyl)-purine (compound III)

[0053] Dissolve 12.0 g of the compound prepared in Example 1 in 100 mL of dichloromethane solution, transfer it to a 500 mL three-neck flask, add 200 mL of acetonitrile, and put in 5.0 g of 2,6-dichloropurine and 0.5 g of calcium hydride in sequence under nitrogen protection , Put 1.25g of sodium hydride into the reaction flask, and stir at room temperature for 12-16h. TLC: Ethyl acetate: Petroleum ether = 1:4, the reaction is complete, filter, wash the filter cake with a small amount of dichloromethane, adjust the pH of the filtrate to 6-8 with glacial acetic acid, filter again if there is precipitation, concentrate the mother liquor to dryness, add 20 mL of ethyl acetate The ester was heated to dissolve, and 20 mL of methanol was added while it was hot, and cooled to crystallize. After cooling down to room temperature naturally, it was cooled in an ice ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for synthesizing clofarabine; the method comprises the following synthetic routes described in the specification, wherein in the formula III and the formula IV, R1 and R2 are the same or different acyl groups. The method comprises the following steps: 1) ammoniation: dissolving a compound represented by the formula III in an organic solvent, introducing ammonia gas, and carrying out a closed reaction, to obtain a compound represented by the formula IV after the reaction is completed, wherein the organic solvent is any combination of one or two or more of acetonitrile, ethyl acetate, dichloromethane and tetrahydrofuran, the concentration of ammonia gas dissolved in the organic solvent is 0.1-20 wt%, the closed reaction is carried out for 10-40 hours, and the reaction temperature is 0-100 DEG C; and 2) protecting group removal: dissolving the compound represented by the formula IV and prepared in the step 1) in alcohol, adding an alcohol solution of sodium alkoxide, carrying out a reaction, then adjusting the pH value to 6-7, cooling and crystallizing, and thus obtaining a clofarabine crude product.

Description

technical field [0001] The invention belongs to the technical field of medicine and chemical industry, and in particular relates to a synthesis method of clofarabine. Background technique [0002] Clofarabine (Clofarabine), chemical name: 2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuran)-9H-purin-6-amine, is produced by the Birmingham Southern Institute of the United States Developed and authorized the nucleoside anti-leukemia drug jointly developed by British Bioenvision Company and American Ilexoncology Company, which was first launched in the United States in 2005. It is used for patients with relapsed or refractory acute lymphoblastic leukemia aged 1 to 21 years after at least two treatment methods fail. [0003] Clofarabine inhibits the action of nucleotide reductase, reduces the storage of deoxynucleoside triphosphates in cells, and inhibits DNA synthesis; binds to DNA chains, competitively inhibits DNA polymerase, and stops the elongation and repair of DNA chains. Clof...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07H19/19C07H1/00
CPCY02P20/55
Inventor 程志刚代旭勇陈亮王旭东刘浩
Owner WUHAN BIOCAUSE PHARMA DEV